Yuen Sheung Law
羅婉湘
This page summarises the Hong Kong Securities and Futures Commission (SFC) public register record for Yuen Sheung Law (羅婉湘), a licensed Representative with CE reference APL590. Currently licensed at 1 firm(s): Huatai Financial Holdings (Hong Kong) Limited. Active regulated activities: Type 4 - Advising on securities. This person has 11.6 years of SFC licence history. Total licence records on file: 12.
Information
- LinkedIn:
- Email:
Licence history
| Firm | Role | Regulated activity | From | To |
|---|---|---|---|---|
| Huatai Financial Holdings (Hong Kong) Limited 華泰金融控股(香港)有限公司 |
Rep | Type 4 - Advising on securities | 2025-06-09 | present |
| Cosmos One Capital Limited 宏銘資本有限公司 |
Rep | Type 1 - Dealing in securities | 2024-07-11 | 2025-05-01 |
| Cosmos One Capital Limited 宏銘資本有限公司 |
Rep | Type 4 - Advising on securities | 2024-07-11 | 2025-05-01 |
| Cosmos One Capital Limited 宏銘資本有限公司 |
Rep | Type 9 - Asset management | 2024-07-11 | 2025-05-01 |
| Haitong International Research Limited 海通國際研究有限公司 |
RO | Type 4 - Advising on securities | 2018-05-29 | 2020-10-23 |
| Haitong International Research Limited 海通國際研究有限公司 |
Rep | Type 4 - Advising on securities | 2018-02-21 | 2018-05-29 |
| BOCI Research Limited 中銀國際研究有限公司 |
RO | Type 4 - Advising on securities | 2017-04-10 | 2017-12-29 |
| BOCI Research Limited 中銀國際研究有限公司 |
Rep | Type 4 - Advising on securities | 2015-04-22 | 2017-04-10 |
| Daiwa Capital Markets Hong Kong Limited 大和資本市場香港有限公司 |
Rep | Type 4 - Advising on securities | 2010-11-15 | 2012-02-21 |
| Daiwa Institute of Research (Hong Kong) Limited 大和總研(香港)有限公司 |
Rep | Type 4 - Advising on securities | 2010-11-15 | 2012-01-30 |
| Merrill Lynch (Asia Pacific) Limited | Rep | Type 4 - Advising on securities | 2010-04-08 | 2010-09-01 |
| Merrill Lynch (Asia Pacific) Limited | Rep | Type 1 - Dealing in securities | 2007-08-22 | 2010-09-01 |
Worked alongside
The 20 closest colleagues, strongest tie first — individuals licensed at the same firm as Yuen Sheung Law during overlapping periods. Ranked by how long they overlapped and how similar their regulated activities were, with shared time at a smaller firm weighted more than at a large one. See the detailed formula.
| Name | Shared firm | Overlap |
|---|---|---|
| Yong Wang | Haitong International Research Limited | 2018–2020 |
| Qinrui Zhang | BOCI Research Limited | 2015–2017 |
| Chi Sing Lau | BOCI Research Limited | 2015–2017 |
| Xin Meng | BOCI Research Limited | 2015–2017 |
| Qiong Wu | BOCI Research Limited | 2015–2017 |
| Wenzhou Hu | BOCI Research Limited | 2015–2017 |
| Yusheng Liu | BOCI Research Limited | 2015–2017 |
| Jia Lou | BOCI Research Limited | 2015–2017 |
| Shiu Ki Mak | BOCI Research Limited | 2015–2017 |
| Bingnan Ye | BOCI Research Limited | 2015–2017 |
| Chen Shen | BOCI Research Limited | 2015–2017 |
| Michelle Ka Ki Ho | BOCI Research Limited | 2015–2017 |
| Wei Wang | BOCI Research Limited | 2015–2017 |
| Manjiang Cheng | BOCI Research Limited | 2015–2017 |
| Jiaying Huang | BOCI Research Limited | 2015–2017 |
| Tingting Li | BOCI Research Limited | 2015–2017 |
| Yaogang Zhang | BOCI Research Limited | 2015–2017 |
| Xinyuan Li | BOCI Research Limited | 2015–2017 |
| Yee Hin Chow | Haitong International Research Limited | 2018–2020 |
| Ji Shi | Haitong International Research Limited | 2018–2020 |